These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3915365)
1. Thalidomide and congeners as anti-inflammatory agents. Koch HP Prog Med Chem; 1985; 22():165-242. PubMed ID: 3915365 [No Abstract] [Full Text] [Related]
2. Thalidomide for dermatology: a review of clinical uses and adverse effects. Faver IR; Guerra SG; Su WP; el-Azhary R Int J Dermatol; 2005 Jan; 44(1):61-7. PubMed ID: 15663665 [No Abstract] [Full Text] [Related]
3. Thalidomide therapy for inflammatory dermatoses. Grosshans E; Illy G Int J Dermatol; 1984 Nov; 23(9):598-602. PubMed ID: 6097551 [No Abstract] [Full Text] [Related]
4. Thalidomide in dermatology. New indications for an old drug. Calderon P; Anzilotti M; Phelps R Int J Dermatol; 1997 Dec; 36(12):881-7. PubMed ID: 9466191 [No Abstract] [Full Text] [Related]
5. Thalidomide in dermatology and leprosy. Lancet; 1985 Jul; 2(8446):80-1. PubMed ID: 2861530 [No Abstract] [Full Text] [Related]
6. [Current therapeutic indications of thalidomide and lenalidomide]. Ordi-Ros J; Cosiglio FJ Med Clin (Barc); 2014 Apr; 142(8):360-4. PubMed ID: 23830554 [TBL] [Abstract][Full Text] [Related]
7. Thalidomide in leprosy and some dermatological conditions--a review. Parikh DA; Maniar JK; Ganapati R Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010 [No Abstract] [Full Text] [Related]
8. Thalidomide: is it any wonder? Hampshire M Nurs Times; 1998 Aug 26-Sep 1; 94(34):14-5. PubMed ID: 9791503 [No Abstract] [Full Text] [Related]
9. The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide. Sheskin J Int J Dermatol; 1980; 19(6):318-22. PubMed ID: 7005131 [No Abstract] [Full Text] [Related]
17. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage. Naafs B Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120 [No Abstract] [Full Text] [Related]
18. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders. Millrine D; Kishimoto T Trends Mol Med; 2017 Apr; 23(4):348-361. PubMed ID: 28285807 [TBL] [Abstract][Full Text] [Related]
19. The evolution of thalidomide and its IMiD derivatives as anticancer agents. Bartlett JB; Dredge K; Dalgleish AG Nat Rev Cancer; 2004 Apr; 4(4):314-22. PubMed ID: 15057291 [No Abstract] [Full Text] [Related]
20. [Thalidomide and thrombosis]. Schmutz JL; Barbaud A; Trechot P Ann Dermatol Venereol; 2003 Apr; 130(4):489. PubMed ID: 12843869 [No Abstract] [Full Text] [Related] [Next] [New Search]